Comparison of censoring assumptions to reduce bias in tuberculosis treatment cohort analyses.

by Meredith B Brooks, Carole D Mitnick, Justin Manjourides
Published 2020-01-01

Second line drug susceptibility testing to inform the treatment of rifampin-resistant tuberculosis: a quantitative perspective

by Emily A. Kendall, Ted Cohen, Carole D. Mitnick, David W. Dowdy
Published 2017-03-01

Randomized trials to optimize treatment of multidrug-resistant tuberculosis.

by Carole D Mitnick, Kenneth G Castro, Mark Harrington, Leonard V Sacks, William Burman
Published 2007-11-01

A systematic review of reported cost for smear and culture tests during multidrug-resistant tuberculosis treatment.

by Chunling Lu, Qing Liu, Aartik Sarma, Christopher Fitzpatrick, Dennis Falzon, Carole D Mitnick
Published 2013-01-01

Tuberculosis and chronic respiratory disease: a systematic review

by Anthony L. Byrne, Ben J. Marais, Carole D. Mitnick, Leonid Lecca, Guy B. Marks
Published 2015-03-01

Long-term Follow-up for Multidrug-resistant Tuberculosis

by Sonya S. Shin, Jennifer J. Furin, Felix Alcántara, Jaime Bayona, Epifanio Sánchez, Carole D. Mitnick
Published 2006-04-01

Preliminary clinical outcomes from the Peruvian National Cataract Elimination Plan Resultados clínicos preliminares del Plan Nacional de Lucha contra la Ceguera por Catarata del Pe...

by Tomasz P. Stryjewski, Daniel Bitrán Benadretti, Sihai Dave Zhao, Susannah Rowe, Carole D. Mitnick
Published 2010-10-01

Use of predicted vital status to improve survival analysis of multidrug-resistant tuberculosis cohorts

by Meredith B. Brooks, Salmaan Keshavjee, Irina Gelmanova, Nataliya A. Zemlyanaya, Carole D. Mitnick, Justin Manjourides
Published 2018-12-01

Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape.

by Patrick P J Phillips, Carole D Mitnick, James D Neaton, Payam Nahid, Christian Lienhardt, Andrew J Nunn
Published 2019-03-01

Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis

by Jonathon R. Campbell, Dennis Falzon, Fuad Mirzayev, Ernesto Jaramillo, Giovanni Battista Migliori, Carole D. Mitnick, Norbert Ndjeka, Dick Menzies
Published 2020-03-01

Propensity Score-Based Approaches to Confounding by Indication in Individual Patient Data Meta-Analysis: Non-Standardized Treatment for Multidrug Resistant Tuberculosis.

by Gregory J Fox, Andrea Benedetti, Carole D Mitnick, Madhukar Pai, Dick Menzies, Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB
Published 2016-01-01

Asthma and atopy prevalence are not reduced among former tuberculosis patients compared with controls in Lima, Peru

by Anthony L. Byrne, Ben J. Marais, Carole D. Mitnick, Frances L. Garden, Leonid Lecca, Carmen Contreras, Yaninna Yauri, Fanny Garcia, Guy B. Marks
Published 2019-02-01

Chronic airflow obstruction after successful treatment of multidrug-resistant tuberculosis

by Anthony L. Byrne, Ben J. Marais, Carole D. Mitnick, Frances L. Garden, Leonid Lecca, Carmen Contreras, Yaninna Yauri, Fanny Garcia, Guy B. Marks
Published 2017-07-01

Treatment Outcomes for Adolescents With Multidrug-Resistant Tuberculosis in Lima, Peru

by Dylan B. Tierney MD MPH, Meredith B. Milstein MPH, Justin Manjourides PhD, Jennifer J. Furin MD PhD, Carole D. Mitnick ScD
Published 2016-10-01

Management of extensively drug-resistant tuberculosis in Peru: cure is possible.

by Cesar A Bonilla, Aldo Crossa, Hector O Jave, Carole D Mitnick, Ronal B Jamanca, Cesar Herrera, Luis Asencios, Alberto Mendoza, Jaime Bayona, Matteo Zignol, Ernesto Jaramillo
Published 2008-01-01

Access to new medications for the treatment of drug-resistant tuberculosis: Patient, provider and community perspectives

by Erica Lessem, Helen Cox, Colleen Daniels, Jennifer Furin, Lindsay McKenna, Carole D. Mitnick, Thato Mosidi, Caitlin Reed, Barbara Seaworth, Jonathan Stillo, Phumeza Tisile, Dalene von Delft
Published 2015-03-01

Acquired and Transmitted Multidrug Resistant Tuberculosis: The Role of Social Determinants.

by Anna Odone, Roger Calderon, Mercedes C Becerra, Zibiao Zhang, Carmen C Contreras, Rosa Yataco, Jerome Galea, Leonid Lecca, Matthew H Bonds, Carole D Mitnick, Megan B Murray
Published 2016-01-01

The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens

by Uzma Khan, Helena Huerga, Aamir J. Khan, Carole D. Mitnick, Catherine Hewison, Francis Varaine, Mathieu Bastard, Michael Rich, Molly F. Franke, Sidney Atwood, Palwasha Y. Khan, Kwonjune J. Seung
Published 2019-08-01

Scaling up programmatic management of drug-resistant tuberculosis: a prioritized research agenda.

by Frank G J Cobelens, Einar Heldal, Michael E Kimerling, Carole D Mitnick, Laura J Podewils, Rajeswari Ramachandran, Hans L Rieder, Karin Weyer, Matteo Zignol, Working Group on MDR-TB of the Stop TB Partnership
Published 2008-07-01

Time to culture conversion and regimen composition in multidrug-resistant tuberculosis treatment.

by Dylan B Tierney, Molly F Franke, Mercedes C Becerra, Félix A Alcántara Virú, César A Bonilla, Epifanio Sánchez, Dalia Guerra, Maribel Muñoz, Karim Llaro, Eda Palacios, Lorena Mestanza, Rocío M Hurtado, Jennifer J Furin, Sonya Shin, Carole D Mitnick
Published 2014-01-01